London Jobs |
Manchester Jobs |
Liverpool Jobs |
Nottingham Jobs |
Birmingham Jobs |
Cambridge Jobs |
Glasgow Jobs |
Bristol Jobs |
Wales Jobs |
London Jobs |
Manchester Jobs |
Liverpool Jobs |
Nottingham Jobs |
Birmingham Jobs |
Cambridge Jobs |
Glasgow Jobs |
Bristol Jobs |
Wales Jobs |
Oil & Gas Jobs |
Banking Jobs |
Construction Jobs |
Top Management Jobs |
IT - Software Jobs |
Medical Healthcare Jobs |
Purchase / Logistics Jobs |
Sales |
Ajax Jobs |
Designing Jobs |
ASP .NET Jobs |
Java Jobs |
MySQL Jobs |
Sap hr Jobs |
Software Testing Jobs |
Html Jobs |
Job Location | Cambridge |
Education | Not Mentioned |
Salary | Competitive salary |
Industry | Not Mentioned |
Functional Area | Not Mentioned |
Job Type | Permanent, full-time |
Cancer Research UK-AstraZeneca Antibody Alliance Laboratory: Scientist/Senior Scientist - Phage display and Antibody DiscoveryLocation: Granta Park, CambridgeContract: 12-month Fixed term, Full Time (35 hours per week)Salary: £28,000 - £42,000Closing date: Midnight 24th January 2021. Please do not delay applying as we will be shortlisting on application.Application process: CV and application questions via our careers pageAre you a passionate research scientist with a background in antibody phage display or related discipline looking to develop skills in drug discoveryIn collaboration with AstraZeneca, Cancer Research UK (CRUK) has established a pioneering laboratory in Cambridge. The lab deploys cutting edge technologies in order to generate candidate therapeutics, diagnostics and reagent tools. This exciting venture takes AstraZenecas leading discovery technologies and combine them with biological targets arising from CRUKs extensive network of academic investigators.Why we need youWe are now seeking a research scientist with experience of drug discovery to play a pivotal role in the protein science function of the Alliance Laboratory. The post holder will be part of a multi-disciplinary research team focussed on identifying and characterising biotherapeutic candidates to oncology targets and driving onward development to preclinical proof of concept.What will I be doing